Papillary microcarcinoma of the thyroid among atomic bomb survivors: Tumor characteristics and radiation risk

Cancer

Volumn 116, Issue 7, 2010, Pages 1646-1655

  Hayashi, Yuzo ^a   Lagarde, Frederic ^b   Tsuda, Nobuo ^c   Funamoto, Sachiyo ^b   Preston, Dale L ^d   Koyama, Kojiro ^b   Mabuchi, Kiyohiko ^e   Ron, Elaine ^e   Kodama, Kazunori ^b   Tokuoka, Shoji ^b  

^a HIROSHIMA CITY ASA HOSPITAL   (Japan)

^b RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^c Nagasaki General Health Center   (Japan)

^d Hirosoft International   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Atomic bombs; Papillary microcarcinoma; Radiation; Thyroid

Indexed keywords

ADULT; AGED; ARTICLE; ATOMIC BOMB SURVIVOR; AUTOPSY; CALCIFICATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; FEMALE; HISTOPATHOLOGY; HUMAN; IONIZING RADIATION; LIFESPAN; MAJOR CLINICAL STUDY; MALE; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PSAMMOMA BODY; RADIATION DOSE; RADIATION HAZARD; RADIATION RESPONSE; THYROID CARCINOMA; TUMOR VOLUME;

ADENOCARCINOMA, PAPILLARY; AGED; AGED, 80 AND OVER; AUTOPSY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; NUCLEAR WARFARE; NUCLEAR WEAPONS; RADIATION, IONIZING; RISK FACTORS; SURVIVORS; THYROID NEOPLASMS;

EID: 77950220926     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24872     Document Type: Article

References (39)

1. K Kasagi. [Epidemiology of thyroid tumors: effect of environmental iodine intake]. Nippon Rinsho. 2007;65:1953-1958.
2. Kent WD, Hall SF, Isotalo PA, Houlden RL, George RL, Groome PA. Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease. CMAJ. 2007;177:1357-1361.
3. Colonna M, Guizard AV, Schvartz C, et al. A time trend analysis of papillary and follicular cancers as a function of tumour size: a study of data from 6 cancer registries in France. 1983-2000. Eur J Cancer. 2007;43:891-900.
4. Burgess JR, Tucker P. Incidence trends for papillary thyroid carcinoma and their correlation with thyroid surgery and thyroid fine-needle aspirate cytology. Thyroid. 2006;16:47-53.
5. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295:2164-2167.
6. How J, Tabah R. Explaining the increasing incidence of differentiated thyroid cancer. CMAJ. 2007;177:1383-1384.
7. Hedinger, C, Williams ED, Sobin LH. Histological Typing of Thyroid Tumours (WHO. World Health Organization. International Histological Classification of Tumours). New York: Springer; 1993.
8. Roti E, Rossi R, Trasforini G, et al. Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. J Clin Endocrinol Metab. 2006;91:2171-2178.
9. Baloch ZW, LiVolsi VA. Microcarcinoma of the thyroid. Adv Anat Pathol. 2006;13:69-75.
10. Nasir A, Chaudhry AZ, Gillespie J, Kaiser HE, Papillary microcarcinoma of the thyroid: a clinico-pathologic and prognostic review. In Vivo. 2000;14:367-376.
11. Piersanti M, Ezzat S, Asa SL. Controversies in papillary microcarcinoma of the thyroid. Endocr Pathol. 2003;14:183-191.
12. Ron E, Schneider AB. Thyroid Cancer. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer Epidemiology and Prevention. New York: Oxford University Press; 2006:975-994.
13. United Nations Scientific Committee on the Effects of Atomic Radiation, Sources and effects of ionizing radiation: United Nations Scientific Committee on the Effects of Atomic Radiation UNSCEAR 2000 Report to the General Assembly, with scientific annexes, Vol 2: Effects. United Nations, New York, 2000.
14. Young RW, Kerr GD, eds. Reassessment of the Atomic-Bomb Radiation Dosimetry for Hiroshima and Nagasaki: Dosimetry System 2002 Radiation Effects Research Foundation, Hiroshima, Japan, 2005.
15. Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. Radiat Res. 2003;160:381-407.
16. Preston DL, Ron E, Tokuoka S, et al. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res. 2007;168:1-64.
17. Mabuchi K, Soda M, Ron E, et al. Cancer incidence in atomic bomb survivors. Part I: use of the tumor registries in Hiroshima and Nagasaki for incidence studies. Radiat Res. 1994;137(suppl 2):S1-S16.
18. Angevine DM, Jablon S, Matsumoto YS. JNIH-ABCC pathology studies, Hiroshima-Nagasaki report 1, October 1950-September 1960. Natl Cancer Inst Monogr. 1963;19:445-465.
19. Beebe GW, Yamamoto T, Matsumoto YS, Gould SE. ABCC-JNIH pathology studies, Hiroshima-Nagasaki report 2, October 1950-December 1965, Hiroshima Igaki. 1968;21:729-735.
20. ABCC-JNIH pathology studies research plan. Radiation Effects Research Foundation, Hiroshima, 1962.
21. Pierce DA, Stram DO, Vaeth M. Allowing for random errors in radiation dose estimates for the atomic bomb survivor data. Radiat Res. 1990;123:275-284.
22. Preston DL, Lubin JH, Pierce DA, McConney ME. Epicure users guide. Hirosoft International Corporation, Seattle, Washington, 1993.
23. Yamamoto Y, Maeda T, Izumi K, Otsuka H. Occult papillary carcinoma of the thyroid. A study of 408 autopsy cases. Cancer. 1990;65:1173-1179.
24. de Matos PS, Ferreira AP, Ward LS. Prevalence of papillary microcarcinoma of the thyroid in Brazilian autopsy and surgical series. Endocr Pathol. 2006;17:165-173.
25. Kaneko N, Numata J. An autopsy case of atomic radiation-induced leukmia complicated with thyroid gland tumor [in Japanese]. J Pediatr Pract. 1957;20:478.
26. Fujimoto Y, Yamamoto T, Numata J, Mori K. Two autopsy cases of thyroid cancer in young atomic bomb survivors [in Japanese]. J Hiroshima Med Assoc. 1959;12:519-524.
27. Hollingsworth DR. Radiation and carcinoma of the thyroid. Conn Med. 1963;27:762-765.
28. Socolow EL, Hashizume A, Neriishi S, Niitani R. Thyroid carcinoma in man after exposure to ionizing radiation. A summary of the findings in Hiroshima and Nagasaki. N Engl J Med. 1963;268:406-410.
29. Wood JW, Tamagaki H, Neriishi S, et al. Thyroid carcinoma in atomic bomb survivors Hiroshima and Nagasaki. Am J Epidemiol. 1969;89:4-14.
30. Parker LN, Belsky JL, Yamamoto T, Kawamoto S, Keehn RJ. Thyroid carcinoma after exposure to atomic radiation. A continuing survey of a fixed population, Hiroshima and Nagasaki, 1958-1971. Ann Intern Med. 1974;80:600-604.
31. Sampson RJ, Key CR, Buncher CR, Iijima S. Thyroid carcinoma in Hiroshima and Nagasaki. I. Prevalence of thyroid carcinoma at autopsy. JAMA. 1969;209:65-70.
32. Sampson RJ, Key CR, Buncher CR, Iijima S. The smallest forms of papillary carcinoma of the thyroid. A study of 141 microcarcinomas less than 0.1 cm in greatest dimension. Arch Pathol. 1971;91:334-339.
33. Yoshimoto Y, Ezaki H, Etoh R, Hiraoka T, Akiba S. Prevalence rate of thyroid diseases among autopsy cases of the atomic bomb survivors in Hiroshima, 1951-1985. Radiat Res. 1995;141:278-286.
34. Richardson DB. Exposure to ionizing radiation in adulthood and thyroid cancer incidence. Epidemiology. 2009;20:181-187.
35. Damber L, Larsson LG, Johansson L, Norin T. A cohort study with regard to the risk of haematological malignancies in patients treated with x-rays for benign lesions in the locomotor system. I. Epidemiological analyses. Acta Oncol. 1995;34:713-719.
36. Huang J, Walker R, Groome PG, Shelley W, Mackillop WJ. Risk of thyroid carcinoma in a female population after radiotherapy for breast carcinoma. Cancer. 2001;92:1411-1418.
37. Ronckers CM, Erdmann CA, Land CE. Radiation and breast cancer: a review of current evidence. Breast Cancer Res. 2005;7:21-32.
38. Roychoudhuri R, Evans H, Robinson D, Moller H. Radiation-induced malignancies following radiotherapy for breast cancer. Br J Cancer. 2004;91:868-872.
39. Adjadj E, Rubino C, Shamsaldim A, Le MG, Schlumberger M, de Vathaire F. The risk of multiple primary breast and thyroid carcinomas. Cancer. 2003;98:1309-1317.